نتایج جستجو برای: non alcoholic steatohepatitis

تعداد نتایج: 1341204  

Journal: :Journal of Endocrinology and Diabetes 2016

Journal: :European medical journal 2022

Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions world on trajectory to become at a global scale. Risk for high prevalence progressiveness include visceral obesity Type 2 diabetes. The conundrum related rapid increase its burden with low awareness among general providers, as well...

Journal: :European review for medical and pharmacological sciences 2005
A Grieco A Forgione L Miele V Vero A V Greco A Gasbarrini G Gasbarrini

Drug-induced liver diseases (DILD) are clinico-pathologic patterns of liver injury caused by drugs or other foreign compounds. Steatohepatitis is a rare form of DILD, and drugs account for fewer than 2% of non-alcoholic steatohepatitis (NASH). Drugs known to be capable of inducing steatosis and steatohepatitis can be divided into three broad groups: those that cause steatosis and steatohepatiti...

2015
Sheetal Sanjay Desai Sanjay Vithalrao Desai

Background: Non-alcoholic fatty liver disease (NAFLD) has become over the last decade the most common form of chronic liver disease in children and adults. It is tightly associated with obesity and threatens to become a serious public health problem. Non-alcoholic steatohepatitis (NASH) is also commonly associated with type 2 diabetes mellitus (DM). Therefore, this study was carried out to know...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید